The economics of glycemic control in the ICU in the United States

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 14, Issue 2, 2011, Pages 209-212

  Scurlock, Corey ^a   Raikhelkar, Jayashree ^a   Mechanick, Jeffrey I ^b  

^a Cardiothoracic Intensive Care Unit   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

affordable care act; glycemic control; national debt; value based care

Indexed keywords

INSULIN;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; ECONOMIC ASPECT; GLYCEMIC CONTROL; HEALTH CARE COST; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INTENSIVE CARE UNIT; LENGTH OF STAY; MORBIDITY; MORTALITY; RENAL REPLACEMENT THERAPY; UNITED STATES;

BLOOD GLUCOSE; COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; HEALTH CARE COSTS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE; TREATMENT OUTCOME; UNITED STATES;

EID: 79952039951     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283437bc4     Document Type: Article

References (19)

1. Organization for Economic Cooperation and Development (OECD). Gross domestic product. http://stats.oecd.org/Index.aspx?DatasetCode=SNA. [Accessed 2 October 2010].
2. Centers forMedicare and Medicaid Services. National health expenditure fact sheet. http://www1.cms.gov/NationalHealthExpendData/25NHEFactSheet. asp. [Accessed 2 October 2010]
3. Chernew ME, Baicker K, Hsu J. The specter of financial Armageddon: health care and federal debt in the United States. N Engl J Med 2010;362:1166-1168.
4. Jacobs P, Noseworthy TW. National estimates of intensive care utilizations and costs: Canada and the United States. Crit Care Med 1990;18:1282-1286. (Pubitemid 20377783)
5. World Health Organization. World health report 2000. http://www.who.int/ whr/2000/annex/en/. [Accessed 10 February 2010]
6. Nolte E, McKee CM. Measuring the health of nations: updating an earlier analysis. Health Aff (Millwood) 2008;27:58-71. (Pubitemid 351198590)
7. Porter ME. A strategy for health care reform: toward a value-based system. N Engl J Med 2009;361:109-112.
8. Porter ME. 'How competitive forces shape strategy'. Harvard Business Review;1979.
9. Van den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med 2006;34:612-616.
10. Kinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest 2006;129:644-650.
11. Kinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004;79:992-1000.
12. Sadhu AR, Ang AC, Ingram-Drake LA, et al. Economic benefits of intensive insulin therapy in critically ill patients. The Targeted Insulin Therapy to Improve Hospital Outcomes (TRIUMPH) project. Diabetes Care 2008;31:1556-1561.
13. Signal M, Pretty CG, Chase JG, Le Compte A, Shaw GM. Continuous glucose monitors and the burden of tight glycemic control in critical care: can they cure the time cost? J Diabetes Sci Technol 2010;4:635-1635.
14. Furnary AP, Zerr KJ, Grunkheimer GL, et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999;67:352-362. (Pubitemid 29176984)
15. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 2004;10 (Suppl 2):21-33.
16. Fuller RL, McCullough EC, Bao MZ, Averill RF. Estimating the costs of potentially preventable hospital acquired complications. Health Care Financ Rev 2009;30:17-32.
17. Saleh SS, Callan M, Therrault M, Landor N. The cost impact of hospitalacquired conditions among critical care patients. Med Care 2010;48:518-526.
18. Lehwaldt D, Kingston M, O'Connor S. Postoperative hyperglycemia of diabetic patients undergoing cardiac surgery: a clinical audit. Nurs Crit Care 2009;14:214-253.
19. Leite SAO, Locatelli SB, Niece SP, et al. Impact of hyperglycemia on morbidity and mortality, length of hospitalization and rates of re-hospitalization in a general hospital setting in Brazil. Diabetol Metab Syndr 2010;2:49.